Skip to main content
. 2012 Dec 19;12:608. doi: 10.1186/1471-2407-12-608

Table 3.

Biological pathways displaying down-regulation (compared with normal mucosa) in SPLs, LPLs, and CRCs

 
 
Nominal p-values of enrichment scores
Pathways n* N vs SPL N vs LPL N vs CRC
1) BIOCARTA AT1R PATHWAY
50
0.047
-
-
2) BIOCARTA BIOPEPTIDES PATHWAY
81
0.027
-
-
3)BIOCARTA IL3 PATHWAY
20
0.044
-
-
4) KEGG ALDOSTERONE REGULATED SODIUM REABSORPTION
51
0.029
-
-
5) KEGG CHEMOKINE SIGNALING PATHWAY
216
0.042
-
-
6) KEGG GAP JUNCTION
100
0.039
-
-
7) KEGG MAPK SIGNALING PATHWAY
400
0.047
-
-
8) KEGG VASCULAR SMOOTH MUSCLE CONTRACTION
152
0.037
-
-
9) REACTOME FORMATION OF PLATELET PLUG
236
0.017
-
-
10) REACTOME FRS2 MEDIATED ACTIVATION
23
0.049
-
-
11) REACTOME HEMOSTASIS
348
0.024
-
-
12) REACTOME METABOLISM OF LIPIDS AND LIPOPROTEINS
256
0.046
-
-
13) REACTOME NRAGE SIGNALS DEATH THROUGH JNK
61
0.041
-
-
14) REACTOME PLATELET ACTIVATION
208
0.018
-
-
15) REACTOME RHO GTPASE CYCLE
132
0.046
-
-
16) REACTOME SEMAPHORIN INTERACTIONS
89
0.031
-
-
17) SA PTEN PATHWAY
27
0.027
-
-
18) REACTOME CAM PATHWAY
32
-
0.042
-
19) REACTOME G ALPHA Z SIGNALLING EVENTS
13
-
0.04
-
20) REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA
23
-
0.037
-
21) REACTOME G PROTEIN ACTIVATION
34
-
0.02
-
22) REACTOME NEURORANSMITTER RECEPTOR BINDING AND DOWNSTREAM TRANSMISSION IN THE POSTSYNAPTIC CELL
115
-
0.035
-
23) BIOCARTA NUCLEARRS PATHWAY
22
-
-
0.009
24) KEGG ASCORBATE AND ALDARATE METABOLISM
19
-
-
0.008
25) KEGG DRUG METABOLISM CYTOCHROME P450
71
-
-
0.017
26) KEGG DRUG METABOLISM OTHER ENZYMES
51
-
-
0.045
27) KEGG LONG TERM POTENTIATION
94
-
-
0.024
28) KEGG METABOLISM OF XENOBIOTICS BY CYTOCHROME P450
69
-
-
0.018
29) KEGG NICOTINATE AND NICOTINAMIDE METABOLISM
26
-
-
0.047
30) KEGG PENTOSE AND GLUCURONATE INTERCONVERSIONS
24
-
-
0.009
31) KEGG NITROGEN METABOLISM
28
-
-
0.024
32) KEGG RETINOL METABOLISM
59
-
-
0.028
33) KEGG STARCH AND SUCROSE METABOLISM
54
-
-
0.014
34) REACTOME ACTIVATION OF NMDA RECEPTOR UPON GLUTAMATE BINDING AND POSTSYNAPTIC EVENTS
62
-
-
0.049
35) REACTOME ETHANOL OXIDATION
8
-
-
0.012
36) REACTOME GLUCURONIDATION
15
-
-
0
37) REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION
9
-
-
0.039
38) REACTOME PHASE II CONJUGATION
62
-
-
0.036
39) BIOCARTA HDAC PATHWAY
44
0.022
0.041
-
40) KEGG GLYCOSPHINGOLIPID BIOSYNTHESIS LACTO AND NEOLACTO SERIES
37
0.041
0.037
-
41) REACTOME ACTIVATION OF KAINATE RECEPTORS UPON GLUTAMATE BINDING
37
0.022
0.01
-
42) REACTOME ADP SIGNALLING THROUGH P2Y PURINOCEPTOR 1
31
0.01
0.01
-
43) REACTOME ADP SIGNALLING THROUGH P2Y PURINOCEPTOR 12
24
0.028
0.021
-
44) REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION
42
0.046
0.028
-
45) REACTOME GLUCAGON TYPE LIGAND RECEPTORS
39
0.042
0.036
-
46) REACTOME GS ALPHA MEDIATED EVENTS IN GLUCAGON SIGNALLING
30
0.015
0.012
-
47) REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA
30
0.034
0.027
-
48) REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS
18
0.045
0.042
-
49) REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS
14
0.049
0.018
-
50) REACTOME OTHER SEMAPHORIN INTERACTIONS
25
0.005
0.005
-
51) REACTOME PLATELET ACTIVATION TRIGGERS
73
0.028
0.047
-
52) REACTOME SIGNAL AMPLIFICATION
39
0.007
0.005
-
53) REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS
28
0.019
0.016
-
54) REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR
26
0.007
0.003
-
55) KEGG GNRH SIGNALING PATHWAY
150
0.017
-
0.008
56) BIOCARTA STATHMIN PATHWAY
34
-
0.034
0.009
57) BIOCARTA PGC1A PATHWAY
37
0.005
0.011
0.008
58) KEGG PPAR SIGNALING PATHWAY
86
0.026
0.034
0.044
59) KEGG PROXIMAL TUBULE BICARBONATE RECLAMATION
25
0.003
0.003
0.011
60) KEGG SULFUR METABOLISM
18
0.047
0.03
0.038
61) REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY
78
0.005
0.006
0.006
62) REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS
23
0.011
0.012
0.022
63) REACTOME P2Y RECEPTORS 18 0.009 0.01 0.036

* n = number of RefSeqs in the pathway.

† measured by RS analysis; only significant p-values (< 0.05) are shown.